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Introduction
Prostate adenocarcinoma is one of the most common cancers, and it is the second leading cause of death among men in the United States [1] . The major cause of death from prostate cancer is the metastasis to the bone and lymph nodes of cancer cells that ultimately resist conventional androgen-deprivation therapy [2] . Because androgen ablation of advanced prostate cancer is often unsuccessful, new therapeutic strategies are needed for its treatment and prevention. Prostate cancer commonly overexpresses several growth factors and their receptors, including epidermal growth factor (EGF) receptor (EGFR). EGFR plays a critical role in tumor growth, and the prostate tissue becomes more susceptible to the growth-promoting action of EGF family growth factors during androgen withdrawal [3, 4] . The general inhibition of tyrosine kinase signaling pathways provides therapeutic advantage against prostate cancer metastasis [5] .
Therefore, inhibiting the activation of growth factor receptors, especially EGFR, may be a promising strategy for the treatment of prostate cancer.
cancer PC-3 cells. Curcumin (from turmeric) is one of the most well-known naturally occurring compounds. It has cancer chemopreventive potential against many types of cancerous cells, including prostate cancer. It is a potent NF-κB inhibitor as well as an inducer of apoptosis. Recent data show that curcumin also has an inhibitory effect on EGFR phosphorylation in PC-3 cells [7] . β−phenylethyl isothiocyanate (PEITC), from cruciferous vegetables, is also a highly potent chemopreventive agent that induces apoptosis in prostate cancer cells [8] and other cell types (Xu et al., 2005 , Oncogene in press). In addition, human epidemiological studies show a statistically significant inverse correlation between dietary intake of vegetables that contain isothiocyanates (ITCs) and the risk for prostate cancer [9, 10] . We undertook the present study to investigate the effects of PEITC and curcumin on critical cellular signaling pathways, including the possible inhibition of EGFR phosphorylation and its downstream cell survival Akt signaling pathway.
There is increasing interest in the combined use of low doses of chemopreventive agents with differing modes of action, rather than the administration of a single agent at a higher dose, as a means of obtaining increased efficacy and minimized toxicity. This approach is extremely important when a promising chemopreventive agent demonstrates significant efficacy but may produce some untoward side effects at higher individually at high doses and in combination at very low dose levels [11] . Lowest dose levels of piroxicam and DFMO administered together were more effective in inhibiting the incidence and multiplicity of colon adenocarcinomas than the individual compounds even at higher levels.
We therefore examined the combination of PEITC and curcumin in PC-3 cells for the potential treatment and prevention of prostate cancer. We focused on cell survival signaling pathways inhibited by PEITC and curcumin. Our results clearly show that combination treatment of PC-3 cells with PEITC and curcumin had a very potent inhibitory effect on the phosphorylation and activation of EGFR and Akt, and on the NF-κB pathway, when compared to single compound treatment. The concerted inhibitory effect of the combination on EGFR and NF-κB led to enhanced apoptotic cell death when compared with the effects of the individual compounds. The combination may thus offer therapeutic advantages in the treatment and prevention of human prostate cancer. 8 were 80% confluent, they were serum-starved for 24 h with MEM medium without fetal bovine serum; the cells were subsequently treated with PEITC and/or curcumin.
MTT assay
The MTT (3-(4, 5-dimethylthiazolyl-2)-2, 5-diphenyltetrazolium bromide) assay was performed to determine cell proliferation. Briefly, PC-3 C4 cells were plated in 48-well plates at a density of 4×10 4 /well. After incubating for 24 h, cells were serum starved overnight. Cells were then treated with different concentrations of curcumin and/or PEITC for 24 h and 48 h, at which time, 20 µg of 5 mg/ml MTT solution was added to each well. After a 2 h incubation, medium was removed and DMSO was applied to the plates. Color intensity of the solubilized formazan was measured at 570 nm with an ELISA plate reader (Bio-TEK Instruments, CA).
Luciferase assay
PC-3 C4 cells were plated overnight in 6-well plates at a density of 5×10 5 /well and aliquot of the supernatant was assayed for luciferase activity with a luciferase kit from Promega (Madison, WI), according to the manufacturer's instructions. The luciferase activity was normalized for protein concentration.
Determination of DNA fragmentation
The detection of nuclear DNA fragmentation was performed as described [12] with some modifications. Briefly, PC-3 C4 cells cultured in 100-mm dishes were resuspended in 200 µl of hypotonic lysis buffer (0.2% Triton X-100, 1 mM EDTA, 10 mM Tris/HCl, pH 7.5) and incubated for 20 min at 4ºC. After centrifugation for 5 min at 14,000 g, the supernatant was collected and incubated with RNase A (400 µg/ml) for 30 min at 37ºC, followed by a digestion with proteinase K ( 200 µg/ml) for 30 min at 50ºC. The fragmented DNA was then precipitated overnight at -20ºC in 50% isopropanol and 0.5 M NaCl and centrifuged for 10 min at 14,000g. Dried pellets were dissolved in 20 µl of ultra-pure water, and the DNA was separated by electrophoresis on a 2% agarose gel at 50 V for 1 h. 
Western blotting
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Results
Combination treatment with curcumin and PEITC has an additive inhibitory effect on cell survival signaling pathways in PC-3 C4 cells
To determine the effects of PEITC, curcumin, and their combination on cell viability, the MTT assay was performed on PC-3 C4 cells at two selected time points
(24 h and 48 h). We selected a single dose of each compound based to use throughout this study based on results from our preliminary studies (25 µM curcumin and 10 µM
PEITC; data not shown). Treatment of the cells with 25 µM curcumin for 24 h or 48 h
did not cause significant cell death, whereas treatment with 10 µM PEITC caused significant cell death. The viability of PEITC-treated cells was 75% and 65% of control viability at 24 h and 48 h, respectively ( Figure 1A) . Notably, the combination treatment had a more potent inhibitory effect on cell viability than PEITC alone, with viability at 60% and 44% of control at 24 h and 48 h, respectively ( Figure 1A ).
We next examined the effects of these two compounds on NF-κB signaling. We measured NF-κB luciferase activity after a 24 h incubation of PC-3 C4 cells, which are stably transfected with an NF-κB luciferase plasmid as we have described previously We next examined pro-survival signals. The Western blots in Figure 1E show that the combination treatment is more effective than single drug treatment at inhibiting phosphorylation of Akt, its upstream target PDK1, and IκBα. The combined effect of 25 µM curcumin and 10 µM PEITC was the most potent compared to combinations of different concentrations tested.
EGFR and NF-κB signaling are activated by EGF
To investigate the effects of EGF on PC-3 C4 cells, we analyzed signaling molecules related to the EGFR pathway. The phosphorylation of EGFR, PI3K (p85), and Akt were detected by Western blotting with antibodies specific to phosphorylated proteins. As shown in Figure 2 , all of these proteins were activated after EGF (100 ng/ml) was added for 10 min. As shown in Figure 3A , curcumin had an inhibitory effect on EGFR phosphorylation as reported previously [7] . However, Figure   3B ).
Combination treatment with PEITC and curcumin significantly inhibits EGFR signaling in PC-3 cells
To corroborate the above observations obtained in PC-3 C4 cells and to further examine the inhibitory effects of the drugs on EGFR signaling pathway, parental PC-3 cells were treated with PEITC alone or in combination with curcumin. Parental PC-3 cells were pretreated for 5 min, followed by EGF (100 ng/ml) treatment for 10 min.
As shown in Figure 4A , EGF-stimulated EGFR activation was attenuated by treatments with PEITC or curcumin. Importantly, the combination treatment showed much more significant inhibition of EGFR phosphorylation than the single treatment, especially with respect to the p-EGFR (Y1068) protein. Densitometry analysis of p-EGFR (Y1068) protein levels (right panel of Figure 4A ) shows that EGF-stimulated EGFR phosphorylation was inhibited by 19%, 53%, and 86% when the cells were treated with curcumin, PEITC, and the combination, respectively.
To analyze the downstream signaling events of the EGFR pathway, we next examined EGF-stimulated phosphorylation of PI3K (p85), which also showed significant inhibition by the combination treatment ( Figure 4A ). In addition, when we examined the downstream signaling molecules Akt and IκBα, levels of p-Akt (S473), pAkt(T308), and IκBα were all significantly inhibited by the combination treatment in PC-3 cells ( Figure 4B ). Densitometry analysis shows that p-Akt (S473) protein levels are decreased by curcumin, PEITC, and combination by 7%, 53%, and 69%, respectively, as compared to EGF alone. Immunofluorescence studies after PEITC treatment confirmed that PEITC significantly inhibits EGF-stimulated EGFR phosphorylation ( Figure 4C ).
These data corroborate very well with that of the PC-3 C4 cells and suggest that both PEITC and curcumin can inhibit EGFR-mediated cell survival signals such as PI3K, Akt, and NFκB. Furthermore, the combination of PEITC and curcumin demonstrated additive inhibitory effects on these critical cell survival signaling proteins and, importantly, in cell survival.
Discussion
Prostate cancer is the second leading cause of death of men in the United States.
While the incidence of prostate cancer has increased steadily over the years, its etiology is still not completely understood. Factors contributing to prostate cancer may involve genetic changes, activated oncogenes, growth factors, hormones, and/or dietary factors.
Both the EGFR and NF-κB signaling pathways are implicated in the survival of androgen insensitive human prostate cell lines such as PC-3 and in advanced prostate cancer in humans [3] . Recent studies have indicated that naturally occurring compounds, such as PEITC and curcumin, are potential therapeutics for the prevention and treatment of human prostate cancer [9, 10, 16] . Therefore, in the present study we asked whether PEITC and curcumin can interfere with the EGFR and NF-κB pathways.
We utilized both parental PC-3 cells as well as PC-3 C4 cells, which have a stably It is well known that EGFR and other growth factor receptors are frequently overexpressed in several types of cancers, including prostate. In fact, the progressive and metastatic growth of prostate cancer has been associated with a significant increase in the expression of EGFR and one of its ligands [17, 18] . Similarly, NF-κB activation in cancer cells has been intensively studied by many groups, and constitutive or improper activation of NF-κB in prostate cancer cells in vitro and in vivo has been recently recognized [19] . Moreover, it has recently been shown that the enzyme NF- Representative EGFR signaling proteins (p-EGFR, p-PI3K (p85), p-Akt, and p-IκBα) were measured using phospho-specific antibodies, which detect phosphorylation at specific residue. Anti-EGFR, anti-PI3K (p85), anti-Akt, and anti-IκBα antibodies were used to determine the total expression levels of each protein. Actin was used to ensure equal protein loading. µM; PEITC, 10 µM, or their combination) in serum-free media. Activated EGFR proteins were measured using four different types of phospho-specific antibodies, which recognize specific phosphorylation sites on tyrosine residues, by Western blotting.
Con, control; C, curcumin; P, PEITC. B, PC-3 C4 cells were pretreated with compounds (curcumin, 25 µM; PEITC, 10 µM, or their combination) for 5 min and then challenged with EGF (100 ng/ml) for 1 h in serum-free media. Activated Akt proteins were measured by Western blotting using phospho-specific antibodies that detect specific phosphorylation sites in Akt. Actin was used to ensure equal protein loading.
Con, control; C, curcumin; P, PEITC. µM; PEITC, 10 µM, or their combination) for 5 min and then stimulated with EGF (100 ng/ml). For evaluation of the EGFR signaling proteins, phospho-specific antibodies against the phosphorylated tyrosine residues (Y845, Y992, and Y1068) of EGFR were used. Phospho-p85, a subunit PI3K, was detected using a specific antibody, which can detect p-YXXM motif (Y, tyrosine; X, amino acid; M, methionine). Actin was used as an equal loading control. Relative fold of activation of p-EGFR (Y1068) was measured by densitometry analysis (right). Con, control; C, curcumin; P, PEITC. B, PC-3 cells were pretreated with compounds for 5 min and then incubated with EGF (100 ng/ml) for 2 h. Phosphorylation of Akt was measured using specific antibody detecting phosphorylation of S473 or T308, by Western blotting. Relative fold activation of p-Akt was measured by densitometry (right). Total protein levels of Akt and actin were used for the Akt expression level and protein equal loading controls, respectively. Phosphorylation of IκBα was also measured by Western blotting using a phospho-specific antibody. Con, control; C, curcumin; P, PEITC. C, PC-3 cells were treated with 0.2% DMSO or 10 µM PEITC for 5 min followed by a 10 min incubation with EGF (100 ng/ml). Phosphorylated EGFR (red) and nuclei (blue) were detected by immunofluorescence analysis using anti p-EGFR (Y1086) and DAPI dye respectively. Pictures with red and blue color were merged. Magnitude: 400-fold;
Con, control. 
